Lung function changes related to diabetes mellitus

被引:61
作者
Hsia, Connie C. W. [1 ]
Raskin, Philip [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
关键词
D O I
10.1089/dia.2007.0227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic microangiopathy targets the lung as it does other organs. Even though respiratory dysfunction in most patients with diabetes is subclinical and rarely the presenting complaint, there are several reasons why pulmonary assessment is important: (1) Pulmonary function testing noninvasively quantifies physiological reserves in a large microvascular bed that is not clinically devastated by diabetes. (2) Subclinical loss of pulmonary reserves becomes overtly debilitating under conditions of stress, such as with aging, chronic hypoxia due to lung disease or high altitude exposure, or volume overload secondary to cardiac and renal failure. (3) Unlike myocardial or skeletal muscle function, pulmonary indices are largely independent of physical fitness. (4) Interpretation of pulmonary function indices is not complicated by secondary sequelae of diabetic end-organ failure or prior therapy. Lung function could provide useful measures of the progression of systemic microangiopathy. (5) Chronic use of inhaled insulin may affect long-term pulmonary function, while preexisting pulmonary dysfunction may alter the absorption and bioavailability of inhaled insulin. This review will discuss the changes in lung function observed in diabetes, their underlying mechanisms, and their physiological and clinical implications.
引用
收藏
页码:S73 / S82
页数:10
相关论文
共 85 条
[21]   Prospective association between lung function and the incidence of diabetes - Findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study [J].
Ford, ES ;
Mannino, DM .
DIABETES CARE, 2004, 27 (12) :2966-2970
[22]   Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus [J].
Fuso, L ;
Cotroneo, P ;
Basso, S ;
DeRosa, M ;
Manto, A ;
Ghirlanda, G ;
Pistelli, R .
CHEST, 1996, 110 (04) :1009-1013
[23]   Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes [J].
Guazzi, M ;
Oreglia, I ;
Guazzi, MD .
DIABETES CARE, 2002, 25 (10) :1802-1806
[24]   Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect [J].
Guazzi, M ;
Brambilla, R ;
De Vita, S ;
Guazzi, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (07) :978-982
[25]   Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure [J].
Guazzi, M ;
Brambilla, R ;
Pontone, G ;
Agostoni, P ;
Guazzi, MD .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (02) :191-197
[26]   APPARENT ACCELERATED AGING OF HUMAN COLLAGEN IN DIABETES-MELLITUS [J].
HAMLIN, CR ;
KOHN, RR ;
LUSCHIN, JH .
DIABETES, 1975, 24 (10) :902-904
[27]   Spirometric reference values from a sample of the general US population [J].
Hankinson, JL ;
Odencrantz, JR ;
Fedan, KB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :179-187
[28]   PULMONARY COMPLICATIONS IN DIABETES-MELLITUS [J].
HANSEN, LA ;
PRAKASH, UBS ;
COLBY, TV .
MAYO CLINIC PROCEEDINGS, 1989, 64 (07) :791-799
[29]   The diabetic lung: Relevance of alveolar microangiopathy for the use of inhaled insulin [J].
Hsia, CCW ;
Raskin, P .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (03) :205-211
[30]   Recruitment of lung diffusing capacity - Update of concept and application [J].
Hsia, CCW .
CHEST, 2002, 122 (05) :1774-1783